Swiggy Fund Raise of ₹14,499 Cr

Swiggy Capital Structure Change

Nippon India Mutual Fund bought about 0.18% of Swiggy, lifting its stake from 4.99% to 5.17%. The disclosure is a non-promoter Reg 29(1) filing covering open-market purchases through October 26, 2026.

Execution

Purchase transactions from November 13, 2024 to October 26, 2026

Swiggy Annual General Meeting

Swiggy's postal ballot seeks shareholder approval to re-appoint two independent directors, Anand Kripalu and Suparna Mitra. E-voting runs until 27 Nov 2026.

Swiggy Other Announcement

Swiggy Limited submitted the Monitoring Agency Report for the quarter ended September 30, 2026, regarding the utilization of IPO and QIP proceeds.

Swiggy Earnings Call Transcript: Key Takeaways

Swiggy is pivoting back to growth, leveraging 'Toing' for affordable food delivery to expand the market while Instamart focuses on high-frequency habit building.

Call

Guides 20% growth

Swiggy Results Update

Swiggy's Q2 FY27 letter reports B2C GOV of ₹20,793 Cr and Adjusted Revenue of ₹7,909 Cr. Food delivery EBITDA reached a record ₹341 Cr at 3.4% margin.

Swiggy Management Change

Swiggy's board approved re-appointment of Anand Kripalu and Suparna Mitra as Non-Executive Independent Directors for five-year terms. Both appointments are subject to shareholder approval.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.